Constrictive pericarditis laboratory findings

Revision as of 18:25, 27 December 2019 by Hudakarman (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Constrictive Pericarditis Microchapters


Patient Information


Historical Perspective



Differentiating Constrictive Pericarditis from other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications, and Prognosis


Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings



Echocardiography and Ultrasound

CT scan


Other Imaging Findings

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Constrictive pericarditis laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Constrictive pericarditis laboratory findings

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Constrictive pericarditis laboratory findings

CDC on Constrictive pericarditis laboratory findings

Constrictive pericarditis laboratory findings in the news

Blogs on Constrictive pericarditis laboratory findings

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Constrictive pericarditis laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Huda A. Karman, M.D.


Constrictive pericarditis lab findings can show evidence of congestive heart failure, or associated protein losing enteropathy, nephrotic syndrome, and LFT abnormalities consistent with hepatic congestion and chylous ascites

Laboratory findings

  • Complete blood count (CBC)
  • Leukocytosis
  • Leukopenia
    • Malignancy and chemotherapeutic agents use
  • Hyponatremia or pseudohyponatremia
  • Contraction alkalosis (hypochloremia with hypercarbia)
  • Elevation of blood urea nitrogen (BUN) levels f
  • Serum creatinine levels are observed
  • Arterial blood gas measurement
  • Metabolic acidosis (ie, low pH and low bicarbonate),
  • Compensatory respiratory alkalosis (ie, decreased partial pressure of carbon dioxide
  • Elevated transaminase levels
  • Hypoalbuminemia (a protein-losing enteropathy (PLE)
  • Proteinuria (nephrotic range)
  • Elevated sedimentation rate (ESR), C-reactive protein (CRP) level (postpericardiotomy syndrome)
  • Brain natriuretic peptide (BNP), mildly increased (<150 ng/L)[1]
  • Antinuclear antibody (ANA) or rheumatoid factor (RF) (associated collagen vascular disorder)
  • Purified protein derivative (PPD) skin test (TB)


  1. Leya FS, Arab D, Joyal D, Shioura KM, Lewis BE, Steen LH; et al. (2005). "The efficacy of brain natriuretic peptide levels in differentiating constrictive pericarditis from restrictive cardiomyopathy". J Am Coll Cardiol. 45 (11): 1900–2. doi:10.1016/j.jacc.2005.03.050. PMID 15936624.